The economic value of knowing BRCA status: BRCA testing for optimizing treatment in recurrent epithelial ovarian cancer.

Expert review of pharmacoeconomics & outcomes research（2023）

引用 0|浏览14

暂无评分

摘要

The economic value of knowing status of all U.S. ROC patients provides short-term and long-term evidence for optimizing treatment.

查看译文

关键词

BRCA,BRCA1,BRCA2,cost-effectiveness,olaparib,ovarian cancer,recurrent epithelial ovarian

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要